Avolta reports another solid set of results for the first half of 2025
Werte in diesem Artikel
Avolta AG / Key word(s): Half Year Results Werbung Werbung AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Delivering on all KPIs with +7.1% CER revenue growth, a CORE EBITDA margin of 9.3%, EPS growth of +28.7% and CHF 216m EFCF. Avolta reaffirms its medium-term outlook. H1 2025 HIGHLIGHTS:
H1 2025 KEY FINANCIAL HIGHLIGHTS Consolidated reported turnover totalled CHF 6,734m with CORE turnover of CHF 6,613m representing growth of +7.1% CER. Organic growth totalled +5.7%. In Q2, organic growth was +6.0%. This momentum underscores our strong and resilient business performance, driven by sustained growth in passenger numbers and spend per passenger. Werbung Werbung H1 2025 KEY OPERATIONAL HIGHLIGHTS The first half of 2025 was marked by continued operational improvements, successful business development, and welcome recognition of our industry leading position. OUTLOOK Avolta confirms its organic growth target of 5%-7% p.a. and is committed to delivering +20-40bps of CORE EBITDA margin improvement and +100-150bps EFCF conversion p.a.. At current exchange rates, 2025 currency translation is expected to be -3%. 1CER Constant Exchange Rate. Werbung Werbung For further information:
End of Inside Information |
Language: | English |
Company: | Avolta AG |
Brunngässlein 12 | |
4010 Basel | |
Switzerland | |
Phone: | +41612664444 |
E-mail: | Headoffice@dufry.com |
Internet: | https://www.avoltaworld.com/ |
ISIN: | CH0023405456 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2177324 |
End of Announcement | EQS News Service |
|
2177324 31-Jul-2025 CET/CEST
Ausgewählte Hebelprodukte auf Avolta (ex Dufry)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Avolta (ex Dufry)
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Avolta (ex Dufry)
Analysen zu Avolta (ex Dufry)
Datum | Rating | Analyst | |
---|---|---|---|
20.03.2013 | Dufry kaufen | Credit Suisse Group | |
20.03.2013 | Dufry kaufen | UBS AG | |
04.02.2013 | Dufry kaufen | Vontobel Research | |
25.01.2013 | Dufry kaufen | Vontobel Research | |
16.01.2013 | Dufry kaufen | Vontobel Research |
Datum | Rating | Analyst | |
---|---|---|---|
20.03.2013 | Dufry kaufen | Credit Suisse Group | |
20.03.2013 | Dufry kaufen | UBS AG | |
04.02.2013 | Dufry kaufen | Vontobel Research | |
25.01.2013 | Dufry kaufen | Vontobel Research | |
16.01.2013 | Dufry kaufen | Vontobel Research |
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2012 | Dufry neutral | Sarasin Research | |
06.11.2012 | Dufry neutral | UBS AG | |
05.11.2012 | Dufry neutral | Sarasin Research | |
10.10.2012 | Dufry neutral | Sarasin Research | |
24.09.2012 | Dufry neutral | Sarasin Research |
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2012 | Dufry underperform | Cheuvreux SA | |
06.11.2012 | Dufry underperform | Cheuvreux SA | |
31.10.2012 | Dufry underperform | Cheuvreux SA |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Avolta (ex Dufry) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen